Bayer has acquired full rights to two drugs partnered with Loxo Oncology, on the same day that the biotech was taken over by Eli Lilly in an $8 billion deal. Bayer first partnered with Loxo on the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback